SCHEMBL4444504

SCHEMBL4444504

CC(C)(C)OC(=O)N(c1cnccc1[N+](=O)[O-])C1CCCNC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPLP1 P05386 11/20 0.35
RPLP0 P05388 11/20 0.35
RPS17 P08708 11/20 0.35
RPSA P08865 11/20 0.35
RPS2 P15880 11/20 0.35
RPL35A P18077 11/20 0.35
RPL7 P18124 11/20 0.35
RPL17 P18621 11/20 0.35
RPS4Y1 P22090 11/20 0.35
RPS3 P23396 11/20 0.35
RPS12 P25398 11/20 0.35
RPL13 P26373 11/20 0.35
RPL10 P27635 11/20 0.35
RPL12 P30050 11/20 0.35
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 11/20 0.35
RPL22 P35268 11/20 0.35
RPL4 P36578 11/20 0.35
RPS19 P39019 11/20 0.35
RPL3 P39023 11/20 0.35
RPL13A P40429 11/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3412297 0.92 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3412292 0.92 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4443619 0.92 RPLP1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4436116 0.86 SLC6A4 (0.34) KCNH2GPR119MEN1KMT2A
SCHEMBL4439944 0.86 KMT2A (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4445128 0.84 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4438072 0.83 MEN1 (0.35) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL4436048 0.82 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410670 0.82 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2
SCHEMBL3410672 0.82 RPLP1 (0.36) RPLP1RPLP0RPS17RPSARPS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed